Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Gurbel

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
American Heart Journal|January 29, 2000
Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency departmentP A Gurbel, D J Kereiakes, M R Dalesandro, et al.
European Journal of Heart Failure|August 10, 2000
Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapyV L Serebruany, S R Murugesan, A Pothula, et al.
Journal of Cardiovascular Pharmacology|August 1, 1996
Hemostatic changes after dietary coenzyme Q10 supplementation in swineV L Serebruany, W R Herzog, S P Atamas, et al.
Molecular Aspects of Medicine|January 1, 1997
Could coenzyme Q10 affect hemostasis by inhibiting platelet vitronectin (CD51/CD61) receptor?V L Serebruany, P A Gurbel, J V Ordoñez, et al.
Journal of Cardiovascular Pharmacology|January 1, 1997
Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expressionV L Serebruany, J V Ordonez, W R Herzog, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2011
Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responsesR F Storey, K P Bliden, R Ecob, et al.
Cardiology|January 21, 2000
Failure of thrombin generation markers to triage patients presenting with chest painM E McKenzie, A Pothula, P A Gurbel, et al.
Clinical Pharmacology and Therapeutics|November 4, 2011
Pharmacodynamic evaluation of clopidogrel plus PA32540: the Spaced PA32540 With Clopidogrel Interaction Gauging (SPACING) studyP A Gurbel, K P Bliden, J Fort, et al.
Pharmacology|August 1, 1996
Pretreatment with an inhibitor of mac-1 alters regional and systemic platelet function during ischemia-reperfusion in swineP A Gurbel, V L Serebruany, S F Komiathy, et al.
Journal of the American College of Cardiology|June 17, 1998
Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary ArteriesP A Gurbel, V L Serebruany, A R Shustov, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
American Heart Journal|January 29, 2000
Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency departmentP A Gurbel, D J Kereiakes, M R Dalesandro, et al.
European Journal of Heart Failure|August 10, 2000
Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapyV L Serebruany, S R Murugesan, A Pothula, et al.
Journal of Cardiovascular Pharmacology|August 1, 1996
Hemostatic changes after dietary coenzyme Q10 supplementation in swineV L Serebruany, W R Herzog, S P Atamas, et al.
Molecular Aspects of Medicine|January 1, 1997
Could coenzyme Q10 affect hemostasis by inhibiting platelet vitronectin (CD51/CD61) receptor?V L Serebruany, P A Gurbel, J V Ordoñez, et al.
Journal of Cardiovascular Pharmacology|January 1, 1997
Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expressionV L Serebruany, J V Ordonez, W R Herzog, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2011
Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responsesR F Storey, K P Bliden, R Ecob, et al.
Cardiology|January 21, 2000
Failure of thrombin generation markers to triage patients presenting with chest painM E McKenzie, A Pothula, P A Gurbel, et al.
Clinical Pharmacology and Therapeutics|November 4, 2011
Pharmacodynamic evaluation of clopidogrel plus PA32540: the Spaced PA32540 With Clopidogrel Interaction Gauging (SPACING) studyP A Gurbel, K P Bliden, J Fort, et al.
Pharmacology|August 1, 1996
Pretreatment with an inhibitor of mac-1 alters regional and systemic platelet function during ischemia-reperfusion in swineP A Gurbel, V L Serebruany, S F Komiathy, et al.
Journal of the American College of Cardiology|June 17, 1998
Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary ArteriesP A Gurbel, V L Serebruany, A R Shustov, et al.
Pageof 8